As part of efforts to better prepare the EU for future health crises, the European Commission has proposed changes to the Medicines Agency’s mandate so that the agency would not have to rely on makeshift arrangements – as it did during the COVID-19 pandemic – to respond to critical issues.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?